4 Myalgic Encephalomyelitis Clinical Trials in Huntsville, AL (2026)

Q: How do I join a clinical trial in Huntsville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntsville research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Huntsville

NCT05918861Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

This is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile. Subjects will prov...

Huntsville, ALPHASE32,000 participantsDalCor Pharmaceuticals

View Study Details

NCT06962800Recruiting

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with PMN, autoantibodies build up in the glome...

Huntsville, ALPHASE3180 participantsBiogen

View Study Details

NCT06808984Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease....

Huntsville, ALPHASE2120 participantsCelgene

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

Huntsville, ALPHASE1120 participantsSystImmune Inc.

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Huntsville

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 4 myalgic encephalomyelitis clinical trials recruiting participants in Huntsville, AL. These studies are seeking a combined 2,420 participants. Research is being sponsored by DalCor Pharmaceuticals, Biogen, Celgene and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Huntsville — FAQ

Are there myalgic encephalomyelitis clinical trials in Huntsville?

Yes, there are 4 myalgic encephalomyelitis clinical trials currently recruiting in Huntsville, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntsville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntsville research site will contact you about next steps.

Are clinical trials in Huntsville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntsville studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 4 active trials in Huntsville are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 19, 2026 from ClinicalTrials.gov